RNAC- Cartesian Therapeutics, Inc.

Name: Cartesian Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Cartesian Therapeutics, Inc. (RNAC) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. RNAC is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Springer Timothy A	8.65M	$74.79M	-
10%	Kalayoglu Murat	511.6K	$4.43M	-
CEO	Brunn Carsten	323.5K	$2.80M	-
CFO	Davis Blaine	121.2K	$1.05M	-
Other	English Emily	94.2K	$815.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 2, 2021	Desilva Nishan M	Director	Buy	7,000	$2.96	$20,722.80	New	-40.5%	-56.3%
Dec 2, 2021	Tan Kevin	Chief Financial Officer	Buy	5,000	$3.03	$15,126.50	New	-40.5%	-56.3%
Dec 2, 2021	Brunn Carsten86	President And CEO	Sale+OE	4,746	$2.96	$14,064.77	-1.6%	-40.5%	-56.3%
Oct 13, 2021	Kishimoto Takashi Kei73	Chief Scientific Officer	Sell	3,892	$4.39	$17,085.88	-2.0%	-35.4%	-63.4%
Oct 13, 2021	Traber Peter G59	Chief Medical Officer	Sell	3,636	$4.39	$15,962.04	-2.3%	-35.4%	-63.4%
Oct 13, 2021	Johnston Lloyd P.74	Chief Operations Officer	Sell	3,892	$4.39	$17,085.88	-3.8%	-35.4%	-63.4%
Oct 13, 2021	Brunn Carsten86	President And CEO	Sell	15,313	$4.39	$67,224.07	-5.2%	-35.4%	-63.4%
Sep 2, 2021	Brunn Carsten86	President And CEO	Sale+OE	4,523	$4.51	$20,398.73	-1.9%	-36.8%	-60.4%
Aug 18, 2021	Barabe Timothy C49	Director	Buy	9,000	$4.00	$36,000.00	+5.0%	-9.2%	-44.1%
Jun 2, 2021	Brunn Carsten86	President And CEO	Sale+OE	4,806	$4.38	$21,040.67	-2.1%	-3.3%	-81.7%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC